NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO). Such investors are advised to contact Peretz Bronstein or his investor relations analyst Yael Hurwitz at email@example.com or 212-697-6484. The investigation concerns whether Diplomat and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On November 2, 2016, Diplomat released its 2016 third quarter results, falling lower than investors' projections. Diplomat also lowered its 2016 full year guidance. Following this news Diplomat stock dropped in value. If you are aware of any facts relating to this investigation, or purchased shares Diplomat, you can assist this investigation by visiting the firm's site: http://www.bgandg.com/dplo. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.